Skip to main content

Co-occurring Medical Disorders

  • Chapter
  • First Online:
Absolute Addiction Psychiatry Review
  • 946 Accesses

Abstract

Substance use can lead to significant medical consequences. Development of these associated diagnoses can be common or rare, and they can vary depending on substance used, frequency, duration, and individual vulnerability. This chapter is organized by substance class and affected organ systems that can vary by substance. These complications may be transient and resolve with substance cessation but can also be irreversible. Prognosis may not be dose-dependent. Some risks are associated with route of administration, independent of substance. Additionally, maternal-fetal risks are possible with complications ranging from low birth weight to fetal demise. By systematically reviewing physical effects of substance use, this structured framework will assist busy clinicians with patient care considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Koguchi K, Nakatsuji Y, Abe K, Sakoda S. Wernicke's encephalopathy after glucose infusion. Neurology. 2004;62(3):512.

    Article  Google Scholar 

  2. Malamud N, Skillicorn SA. Relationship between the Wernicke and the Korsakoff syndrome; a clinicopathologic study of seventy cases. AMA Arch Neurol Psychiatry. 1956;76(6):585–96.

    Article  CAS  Google Scholar 

  3. Beilin LJ, Puddey IB. Alcohol and hypertension: an update. Hypertension. 2006;47(6):1035–8.

    Article  CAS  Google Scholar 

  4. Wood AM, Kaptoge S, Butterworth AS, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513–23.

    Article  Google Scholar 

  5. Runyon BA. A primer on detecting cirrhosis and caring for these patients without causing harm. Int J Hepatol. 2011;2011:801983.

    Article  Google Scholar 

  6. Latvala J, Parkkila S, Niemelä O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res. 2004;28(4):619–24.

    Article  Google Scholar 

  7. Joya X, Friguls B, Ortigosa S, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal. 2012;69:209–22.

    Article  CAS  Google Scholar 

  8. Girard DE, Kumar KL, McAfee JH. Hematologic effects of acute and chronic alcohol abuse. Hematol Oncol Clin North Am. 1987;1(2):321–34.

    Article  CAS  Google Scholar 

  9. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.

    Article  Google Scholar 

  10. Chan TT, Leung WC, Li V, et al. Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study. Psychogeriatrics. 2017;17(5):310–6.

    Article  Google Scholar 

  11. Wikner BN, Källén B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol. 2011;31(3):356–9.

    Article  CAS  Google Scholar 

  12. Bhattacharya P, Taraman S, Shankar L, Chaturvedi S, Madhavan R. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20(5):443–9.

    Article  Google Scholar 

  13. Devlin RJ, Henry JA. Clinical review: major consequences of illicit drug consumption. Crit Care. 2008;12(1):202.

    Article  Google Scholar 

  14. Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med. 2018;170:31.

    Article  Google Scholar 

  15. Thörn SE, Wattwil M, Lindberg G, Säwe J. Systemic and central effects of morphine on gastroduodenal motility. Acta Anaesthesiol Scand. 1996;40(2):177–86.

    Article  Google Scholar 

  16. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–44.

    Article  Google Scholar 

  17. Keefer L, Drossman DA, Guthrie E, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology. 2016.

    Google Scholar 

  18. Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf. 2005;14(11):747–53.

    Article  CAS  Google Scholar 

  19. Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke. 2015;46(3):852–6.

    Article  CAS  Google Scholar 

  20. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol. 2002;39(2):251–6.

    Article  CAS  Google Scholar 

  21. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol. 1998;42(6):535–47.

    Article  CAS  Google Scholar 

  22. Ali MU, Fitzpatrick-Lewis D, Miller J, et al. Screening for abdominal aortic aneurysm in asymptomatic adults. J Vasc Surg. 2016;64(6):1855–68.

    Article  Google Scholar 

  23. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

    Article  Google Scholar 

  24. Hinsberger A, Sharma V, Mazmanian D. Cognitive deterioration from long-term abuse of dextromethorphan: a case report. J Psychiatry Neurosci. 1994;19(5):375–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Mvula MM, Miller JM, Ragan FA. Relationship of phencyclidine and pregnancy outcome. J Reprod Med. 1999;44(12):1021–4.

    CAS  PubMed  Google Scholar 

  26. Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2009;65(3):274–83.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aaron Meyer .

Editor information

Editors and Affiliations

Review Questions

Review Questions

  1. 1.

    Karl is a 50-year-old male with history of alcohol use disorder. He is reviewing his recent laboratory results with his primary care physician, and the physician discusses labs that may indicate some effects on his body from his alcohol use. The most likely lab values they are discussing are:

    1. A.

      Increased platelet count

    2. B.

      Hyperalbuminemia

    3. C.

      Leukopenia

    4. D.

      Gamma glutamyltransferase (GGT)

    5. E.

      Decreased mean corpuscular volume

    Correct answer: D

    Explanation: Markers of synthetic liver function include albumin level, platelet count, and bilirubin. Patients with severe alcohol use disorder often have thrombocytopenia, hypoalbuminemia, and increased total bilirubin. Decreased white count is not a common finding in alcohol use disorder. Liver enzymes that can be elevated with alcohol use include Alanine transaminase (ALT) Aspartate transaminase (AST), as well as GGT. Elevations in GGT may be more specific to alcohol use. Mean corpuscular volume is often increased with chronic alcohol use due to megaloblastic anemia.

  2. 2.

    Candi is a 65-year-old female with a 40 pack/year smoking history. She is a current smoker. What does the United States Preventive Services Task Force (USPSTF) recommend regarding her tobacco use?

    1. A.

      Annual respiratory cultures

    2. B.

      Annual screening non-contrast CT Chest

    3. C.

      Biannual abdominal aorta ultrasound

    4. D.

      Measurement of liver transaminases

    5. E.

      None of the above

    Correct answer: B

    Explanation: USPFTF recommends annual screening non-contrast Chest CT for men and women above the age of 60 with >30 pack/year smoking history. Annual respiratory cultures are not indicated. USPFTF recommends men above the age of 65 who currently smoke with greater than 30 pack/year history to undergo abdominal aorta ultrasound. This recommendation does not apply to women.

  3. 3.

    Hector is a 78-year-old male with generalized anxiety disorder. He has been prescribed clonazepam 1 mg TID for the past 10 years by his primary care physician, but was referred to you, a psychiatrist, after his prescriber retired. During your discussion of the risks of benzodiazepine use, you mention which of the following?

    1. A.

      Thrombocytopenia

    2. B.

      Cognitive impairment, including dementia

    3. C.

      Elevated risk of skin cancer

    4. D.

      Cushing’s syndrome

    5. E.

      Intractable vomiting

    Correct answer: B

    Explanation: Long-term use of benzodiazepines has significant health consequences. Notably, the increased fall risk has led to hip fractures in geriatric populations. Benzodiazepine use has also led to a near doubling of dementia risk. There is no association with skin cancer. There is no association with thrombocytopenia, Cushing’s syndrome, or vomiting. Despite these consequences, prescribers should avoid rapid discontinuation, as this can lead to seizures, withdrawal-associated psychosis.

  4. 4.

    Barry is a 67-year-old guitar player in a band who began using heroin in the 1960s by inhalation, and quickly progressed to IV use for about 15 years. In the 1980s, he began treatment with methadone, and he remained abstinent from heroin for over two decades. Intravenous infectious complications of heroin use include which of the following?

    1. A.

      HIV

    2. B.

      Hepatitis A

    3. C.

      Increased fall risk

    4. D.

      Constipation

    5. E.

      Somnolence

    Correct answer: A

    Explanation: Intravenous heroin use is associated with blood-borne transmission of infections such as HIV and Hepatitis C. Sharing needles can also result in bacteremia, which requires parenteral antibiotics. While constipation is an effect of opioid use, it is not an infectious complication. Somnolence and concomitant increased fall risk is seen with opioid intoxication.

  5. 5.

    After ingesting an unidentified substance, Elmer quickly develops a stabbing feeling radiating to his back. Which emergency condition is most important to consider in your differential diagnosis, and what was the most likely substance involved?

    1. A.

      GERD; alcohol

    2. B.

      Pneumonia; cannabis

    3. C.

      Aortic dissection; cocaine

    4. D.

      Appendicitis; nicotine

    5. E.

      Deep venous thrombosis; cannabis

    Correct answer: C

    Explanation: Cocaine intoxication can cause coronary vasospasm, myocardial infarction, and aortic dissection. Prompt diagnosis and treatment is crucial. None of the other answers are relevant. GERD and pneumonia are not conditions that require emergent treatment. Appendicitis is not a complication of nicotine use.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meyer, A. (2020). Co-occurring Medical Disorders. In: Marienfeld, C. (eds) Absolute Addiction Psychiatry Review. Springer, Cham. https://doi.org/10.1007/978-3-030-33404-8_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-33404-8_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-33403-1

  • Online ISBN: 978-3-030-33404-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics